BusinessAbeona Therapeutics To Present At The Cowen and Company 37th Annual Health Care ConferenceBy Nasdaq OMXMar 7, 2017, 12:45 PM UTC
BusinessAbeona Therapeutics to Present at Maxim Group LLC Biotech Investor & Partnering Conference in ShanghaiBy Nasdaq OMXMar 3, 2017, 12:44 PM UTC
BusinessEarth Science Tech Inc. and Cannabis Therapeutics Inc. to hold High-Level R&D Strategy Session in Laval, Qc and announces Dr. Moutih Rafei, PhD, as a new member of the Advisory BoardBy Nasdaq OMXFeb 28, 2017, 1:00 PM UTC
BusinessEarth Science Tech Initiates its Cannabis Cannabinoid-Based Composition of its 2 New Pharmaceutical Drugs and 3 Nutraceutical Patent StudiesBy Nasdaq OMXFeb 23, 2017, 11:45 AM UTC
BusinessAbeona Therapeutics to Present at the 2017 RBC Capital Markets Global Healthcare Conference and 3rd Annual CRISPR CongressBy Nasdaq OMXFeb 21, 2017, 12:48 PM UTC
BusinessAbeona Therapeutics Provides Update from ABO-102 Phase 1/2 MPS IIIA Clinical Trial at the 13th Annual WORLDSymposium™ 2017By Nasdaq OMXFeb 17, 2017, 12:45 PM UTC
BusinessBiothera Pharmaceuticals to Discuss Imprime PGG Combination Therapy with Checkpoint Inhibitors at Molecular Medicine Tri-Conference 2017By Nasdaq OMXFeb 15, 2017, 3:26 PM UTC
BusinessETST and its wholly owned subsidiary, Cannabis Therapeutics, Signs Joint Venture with Smart Medicines GMP for the Development of its Cannabis Cannabinoid-Based Drugs & NutraceuticalsBy Nasdaq OMXFeb 14, 2017, 12:15 PM UTC
